Intravascular ALK-negative anaplastic large cell lymphoma with localized cutaneous involvement and an indolent clinical course: Toward recognition of a distinct clinicopathologic entity

American Journal of Surgical Pathology

Volumn 37, Issue 4, 2013, Pages 617-623

  Metcalf, Ryan A ^a   Bashey, Sameer ^a   Wysong, Ashley ^a   Kim, Jinah ^a   Kim, Youn H ^a   Gratzinger, Dita ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Veteran's Affairs Palo Alto Health Care System   (United States)

Author keywords

anaplastic large cell lymphoma; cutaneous; intravascular; lymphatic

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; ANTINEOPLASTIC AGENT; PROTEIN TYROSINE KINASE; TUMOR MARKER;

AGED; ARTICLE; CASE REPORT; ENZYMOLOGY; HUMAN; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; MALE; METABOLISM; MULTIMODALITY CANCER THERAPY; PATHOLOGY; REMISSION; SKIN TUMOR; VASCULAR TUMOR;

AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, LARGE-CELL, ANAPLASTIC; MALE; RECEPTOR PROTEIN-TYROSINE KINASES; REMISSION INDUCTION; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; VASCULAR NEOPLASMS;

EID: 84875188378     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e318280aa9c     Document Type: Article

References (22)

1. Swerdlow S. International Agency for Research on Cancer. World Health Organization (WHO) Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: International Agency for Research on Cancer; 2008.
2. Falini B, Pileri S, Zinzani PL, et al. ALK+ lymphoma: clinicopathological findings and outcome. Blood. 1999;93:2697-2706.
3. Savage KJ, Harris NL, Vose JM, et al. ALK-anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project. Blood. 2008;111:5496-5504.
4. Nakashima MO, Roy DB, Nagamine M, et al. Intravascular large B-cell lymphoma: a mimicker of many maladies and a difficult and often delayed diagnosis. J Clin Oncol. 2011;29:e138-e140.
5. Cerroni L, Massone C, Kutzner H, et al. Intravascular large T-cell or NK-cell lymphoma: a rare variant of intravascular large cell lymphoma with frequent cytotoxic phenotype and association with Epstein-Barr virus infection. Am J Surg Pathol. 2008;32:891-898.
6. Wang L, Li C, Gao T. Cutaneous intravascular anaplastic large cell lymphoma. J Cutan Pathol. 2011;38:221-226.
7. Rieger KE, Polidore T, Warnke R, et al. ALK-negative systemic intravascular anaplastic large cell lymphoma presenting in the skin. J Cutan Pathol. 2011;38:216-220.
8. Zizi-Sermpetzoglou A, Petrakopoulou N, Tepelenis N, et al. Intravascular T-cell lymphoma of the vulva, CD30 positive: a case report. Eur J Gynaecol Oncol. 2009;30:586-588.
9. Iacobelli J, Spagnolo D, Tesfai Y, et al. Cutaneous intravascular anaplastic large T-cell lymphoma: a case report and review of the literature. Am J Dermatopathol. 2012;34:e133-e138. [Epub ahead of print]. Available from: http://www-ncbi-nlm-nih-gov.laneproxy.stanford. edu/pubmed/23023016. Accessed October 16, 2012.
10. Krishnan C, Moline S, Anders K, et al. Intravascular ALK-positive anaplastic large-cell lymphoma mimicking inflammatory breast carcinoma. J Clin Oncol. 2009;27:2563-2565.
11. Santucci M, Pimpinelli N, Massi D, et al. Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop. Cancer. 2003;97:610-627.
12. Kuo T, Chen M-J, Kuo M-C. Cutaneous intravascular NK-cell lymphoma: report of a rare variant associated with Epstein-Barr virus. Am J Surg Pathol. 2006;30:1197-1201.
13. Song DE, Lee M-W, Ryu M-H, et al. Intravascular large cell lymphoma of the natural killer cell type. J Clin Oncol. 2007;25: 1279-1282.
14. Wu H, Said JW, Ames ED, et al. First reported cases of intravascular large cell lymphoma of the NK cell type: clinical, histologic, immunophenotypic, and molecular features. Am J Clin Pathol. 2005;123:603-611.
15. Gleason BC, Brinster NK, Granter SR, et al. Intravascular cytotoxic T-cell lymphoma: A case report and review of the literature. J Am Acad Dermatol. 2008;58:290-294.
16. Kahn HJ, Bailey D, Marks A. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas. Mod Pathol. 2002;15:434-440.
17. Pusztaszeri MP, Seelentag W, Bosman FT. Immunohistochemical expression of endothelial markers CD31. CD34, von Willebrand factor, and Fli-1 in normal human tissues. J Histochem Cytochem. 2006;54:385-395.
18. Carbone A, Gloghini A, De Re V, et al. Histopathologic, immunophenotypic, and genotypic analysis of Ki-1 anaplastic large cell lymphomas that express histiocyte-associated antigens. Cancer. 1990;66:2547-2556.
19. Grigorova IL, Panteleev M, Cyster JG. Lymph node cortical sinus organization and relationship to lymphocyte egress dynamics and antigen exposure. Proc Natl Acad Sci USA. 2010;107:20447-20452.
20. Baum CL, Stone MS, Liu V. Atypical intravascular CD30+ T-cell proliferation following trauma in a healthy 17-year-old male: first reported case of a potential diagnostic pitfall and literature review. J Cutan Pathol. 2009;36:350-354.
21. Feldman AL, Law M, Remstein ED, et al. Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas. Leukemia. 2008;23:574-580.
22. Wada DA, Law ME, Hsi ED, et al. Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies. Mod Pathol. 2010;24: 596-605.